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org/licenses/by-nc-nd/4.0/).Abstract Background and aims: For primary prevention of cardiovascular disease (CVD), Cana-
dian guidelines recommend that asymptomatic Canadians with abdominal obesity undergo Fra-
mingham risk score (FRS) assessment, and that in Indigenous Peoples, indicators of metabolic
syndrome also be used to identify at-risk individuals. The hypertriglyceridemic-waist phenotype
(HTGW) has been proposed to be a surrogate marker of visceral obesity and a simple proxy mea-
sure for metabolic syndrome. The primary aim of this study was to evaluate whether the HTGW
and the FRS associated with sub-clinical atherosclerosis.
Methods and results: Asymptomatic Cree participants in a cross-sectional study conducted 2005
e2009 (nZ 446, 18e81 y) were assessed for the HTGW using NCEP-ATP-III gender-speciﬁc-cut-
offs (waist circumference: for men, 102 cm; for women 88 cm) and fasting triglycerides
1.7 mmol/L. Sub-clinical atherosclerosis was deﬁned by the presence of a high sex-speciﬁc
common-carotid-intimal-medial-wall-thickness (75th percentile). HTGW was present in
26.7% and a 10-y FRS greater than 10% was present in 18.8% of participants. The multivariate
adjusted OR (95% CI) for sub-clinical atherosclerosis associated with an FRS greater than 10%
was 4.10 (2.20e7.50) while that associated with the HTGW phenotype was 1.74 (95% CI 1.61
e1.88) from a model including age, body mass index, alcohol consumption, FRS and the HTGW.
Conclusions: The HTGW phenotype is prevalent in the Cree. Our ﬁndings support further study
on the utility of combining the HTGW with the FRS in the prediction of cardiovascular disease
outcomes and in health screening and intervention programs among indigenous peoples.
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Federico II University. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).CAR, Common carotid intimal-to-medial arterial wall thickness; CI, Conﬁdence interval; CVD, Car-
risk score; GEE, Generalized estimated equations; HDL, High density lipoprotein; HTGW, Hyper-
T, Intimal-to-medial arterial wall thickness; NCEP-ATP III, National cholesterol education program
tistically signiﬁcant; OR, Odds ratios.
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Rates of cardiovascular disease (CVD) have been rising
among Canada’s indigenous populations [1] which repre-
sent 4.3% of the total Canadian population [2]. The Cree,
which are the largest indigenous group of North America,
show high diabetes risk [3] and central fat patterning with
weight gain [4e6], which is commonly associated with
increased visceral adiposity and abnormal metabolic pro-
ﬁles over a wide range of body mass indices (BMIs) [7]. For
primary prevention purposes, Canadian guidelines have
recommended that asymptomatic individuals with
abdominal obesity, or at-risk waist circumference (WC), be
initially assessed for the Framingham Risk Score (FRS) [8,9]
which uses age, sex, smoking history, systolic blood pres-
sure, and total and high-density lipoprotein (HDL)
cholesterol, to estimate the 10-year risk of developing total
cardiovascular events [10]. The FRS, however, has not been
validated in indigenous populations and thus its potential
utility for the James Bay Cree is not known. Further,
visceral obesity, in population-based subjects free of CVD,
has been shown to be associated with greater adverse
levels of CVD risk factors as compared to subcutaneous
adipose tissue [11]. Also, visceral obesity has predicted
incident CVD, after adjustments for FRS risk factors and
standard obesity measures including BMI and WC in a
recent study [12].
A proposed surrogate marker of visceral obesity is the
hypertriglyceridemic-waist phenotype (HTGW), which
combines at-risk triglycerides with at-risk waist circum-
ference measurements [13,14]. The HTGW has received
much attention over recent years for its association with
CVD risk factors including risk factors used to calculate the
FRS [13e19] and for its association with coronary artery
disease [14,17]. Although the HTGW has been studied in
Canadian indigenous populations such as the Ojee-Cree
[18] and Inuit [19], it has not been evaluated for its’ asso-
ciation with carotid ultrasound measures of preclinical
atherosclerosis, which has been useful in predicting CVD
[20,21].
Our primary objectives were to evaluate the prevalence
of the HTGW and its’ association with CVD risk factors and
the FRS, and the association of the HTGW and FRS with
subclinical carotid atherosclerosis among the James Bay
Cree.
Methods
Study population
Data for analyses are from the Nituuchischaayihtitaau
Aschii, a large-scale multi-community environment-and-
health longitudinal study held in Eeyou Istchee. Seven
communities were surveyed over a ﬁve year period
(2005e2009). All ages were eligible to participate. The
Nituuchischaayihtitaau Aschii study includes a random
sampling strategy which has been described in detail
elsewhere [22,23]. The total population sizes of the 7
communities studied ranged from 561 to 3820. The Creestudy obtained a certiﬁcate of ethical acceptability by
McGill University and Université Laval and was approved
by the Cree Board of Health and Social Service and by all
communities. Each individual who accepted to participate
in the survey signed an informed consent form. Partici-
pation rates by communities varied between 35% and 56%,
for an overall participation rate equal to 50% [23].
Study participants for analysis
Adult participants (18 y) who had fasted for at least eight
hours at baseline, had complete information, and were not
outliers were included in the present analysis (n Z 737).
We excluded participants with heart disease (n Z 34),
diabetes (n Z 188), and other serious illnesses (n Z 51).
We also excluded pregnant participants (n Z 19). The
above-mentioned exclusions resulted in a sample which
consisted of 446 study participants (226 females and 220
males).
Anthropometric measures
Details on the measurement of anthropometry indices are
described elsewhere [6]. Brieﬂy, waist circumferences
were measured at the end of exhalation with the tape
placed horizontally between the last ﬂoating rib and the
iliac crest. Height and weight were measured at the
baseline physical health examination and BMI calculated
(kg/m2).
Blood collection and lipid analyses
All blood samples were taken under fasting conditions and
stored frozen at 80 C until time of analysis. Plasma tri-
glycerides, total cholesterol, and HDL cholesterol were
analysed using standard enzymatic methods with a Vitros
950 Chemistry Station (Ortho-Clinical Diagnostics, Raritan,
NJ) including manufacturer’s reagents. Analyses were car-
ried out at the biochemistry laboratory of Laval Hospital in
Quebec City as previously described [6].
Blood pressure measurements
Blood pressures were measured using a manual mercury
sphygmomanometer with the mean of the last two of
three blood pressure readings used for analyses as
described elsewhere [6].
Assessment of participant chronic conditions,
demographics and lifestyle factors
Medical ﬁles were used to obtain information on study
participants with regards to chronic conditions and
medication usage. Age, sex, and lifestyle factors (smoking,
alcohol consumption) were collected by questionnaires.
For the present cross-sectional analyses, smoking and
alcohol consumption were considered as categorical vari-
ables (smoking vs. nonsmoking; alcohol drinkers vs. non-
alcohol drinkers).
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The health survey involved measurements of the intimal-
to-medial arterial wall thickness (IMT) of the carotid ar-
teries performed using a high-resolution B-mode ultra-
sound portable device (Model LogiqBook, GE Medical
System, Milwaukee, WI, USA) by two well experienced
sonographers according to a protocol that has previously
been described [24]. In our study population, 25.6% (114/
446) of participants did not have C-CAR measures,
resulting in 332 participants for C-CAR analysis. The ma-
jority 64.5% (73/114) of missing C-CAR values was attrib-
uted to one inland community in which C-CAR measures
were only provided to participants over 40 y of age.
Deﬁnition of the hypertriglyceridemic-waist phenotype
The hypertriglyceridemic-waist (HTGW) phenotype was
deﬁned as an enlarged waist (waist circumference
102 cm in men and 88 cm in women) with an at-risk
fasting triglyceride 1.7 mmol/L [25].
Calculation of the Framingham risk score
The Framingham risk score (FRS) was calculated using
criteria provided in the Canadian Cardiovascular Society
position statement [8] with recent modiﬁcations [9]. The
FRS is based on sex and age stratiﬁed tables with speciﬁc
scores assigned for total and HDL cholesterol levels,
smoking status, and systolic blood pressure (untreated and
treated) and provide an estimate of the 10-y risk of
developing CVD [10]. Individuals with a calculated risk of
10% or less, 10%e19% and 20% or greater were considered
to be at low, moderate, and high risk, respectively.
Statistical analyses
Chi-square tests for differences in proportions evaluated
sex differences of categorical variables by the HTGW
phenotype. Differences in continuous variables between
HTGW phenotype groups were evaluated using mixed
model procedures with HTGWgroups as ﬁxed variable and
region (coastal or inland) as random cluster variable in the
model. Estimated marginal means and SEM are presented.
GEE logistic regression with coastal or inland regions as aTable 1 Prevalence of the hypertriglyceridemic-waist phenotype (HTGW
Tota
At-risk waist circumference (women  88 cm, men  102 cm) 81.2
At-risk triglycerides (1.7 mmol/L) 28.9
HTGW phenotype
Normal waist & normal triglycerides 16.6
Normal waist & at-risk triglycerides 2.2
At-risk waist & normal triglycerides 54.5
At risk waist & at-risk triglycerides 26.7
a ***P < 0.0005; overall Chi-square value for difference between gendercluster variable evaluated the HTGW phenotype’s associ-
ation with having a high FRS (>10%). Similarly GEE ana-
lyses evaluated the extent to which HTGW phenotype and
FRS predicted the presence of sub-clinical atherosclerosis.
Results are presented as odds ratios (OR) and 95% CI in
both univariate and multivariate analyses adjusting for age
(y), BMI (kg/m2) and alcohol consumption (yes vs. no).
Statistical analyses were performed using SAS version 9.4
(SAS Institute, Cary, NC). A P value < 0.05 was considered
statistically signiﬁcant.Results
The distribution of the HTGW and its components in
participants
Abdominal obesity was more common than having an at-
risk triglyceride level (81.2% vs 28.9%, respectively) (Table
1). In addition, the prevalence of an at-risk waist circum-
ference was signiﬁcantly higher in women than in men
(92.9% for females vs. 69.1% for males (P < 0.0005). When
examining for the combined presence of an enlarged waist
and an elevated triglyceride level, 26.7% of study partici-
pants were deﬁned as having the HTGW phenotype.The baseline characteristics of participants according to
HTGW status
Study participants with the HTGW phenotype, as
compared to those without, were signiﬁcantly older, had
higher BMI, waist circumference, systolic blood pressure,
triglyceride and total cholesterol levels, lower HDL
cholesterol levels, and a higher mean FRS (8.14%  1.03% vs
4.31%  0.87%) (Table 2). In addition, those with as
compared to those without the phenotype were more
likely to be in intermediate (21.0% vs. 12.7%) and high (9.2%
vs. 1.9%) risk FRS categories (P < 0.0005) (Table 2).The association of the HTGW with 10-y Framingham risk
score greater than 10% in participants
The 10-y FRS greater than 10% was present in 18.8% of
participants. The HTGW was associated with having a
higher FRS (>10% vs. 10%) in univariate analysis (OR of
2.60; 95% CI 2.44e2.77; P < 0.0005) and in analyses) and its components by sex among Cree adults.
l (nZ 446) Women (n Z 226) Men (n Z 220) P-valuea
92.9 69.1 ***
25.2 32.7 NS
7.1 26.4 ***
0 4.5
67.7 40.9
25.2 28.2
s. NS, non-signiﬁcant difference. Data are %.
Table 2 Baseline characteristics by the hypertriglyceridemic-waist phenotype (HTGW) among Cree adults.a
Variable HTGW() (n Z 327) HTGW(þ) (nZ 119) P-Valueb
Age (y) 33.6  0.72 36.5  1.13 *
Female gender, % 51.7 47.9
Body mass index (kg/m2) 31.6  0.35 35.3  0.47 ***
Waist circumference (cm) 106  0.81 116  1.11 ***
Triglycerides (mmol/L) 1.16  0.05 2.44  0.10 ***
Total cholesterol (mmol/L)c 4.38  0.18 5.20  0.19 ***
HDL cholesterol (mmol/L)c 1.29  0.02 1.11  0.02 ***
Systolic blood pressure (mmHg)d 118  0.68 121  1.22 *
Current smoker, % 60.8 60.5
Alcohol consumption any, % 53.2 52.9
Framingham risk score (%) 4.31  0.87 8.14  1.03 ***
Framingham risk categories ***
<10% (Low) 85.4 69.8
10e20% (Intermediate) 12.7 21.0
>20% (High) 1.9 9.2
a Values presented are estimated marginal means  SEM except where indicated as percent.
b *P < 0.05;***P < 0.0005; linear mixed model regression analysis adjusting for BMI and age, except for weight and BMI which were adjusted
for age, and FRS which was adjusted for BMI.
c Removed participants on cholesterol lowering medication.
d Removed participants on blood pressure lowering medication.
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2.63e3.08; P < 0.0005).
The association of the HTGW with subclinical
atherosclerosis (sex-speciﬁc common-carotid-intimal-
medial-wall-thickness 75th percentile) in participants
The HTGW was associated with the presence of subclinical
atherosclerosis (age-adjusted OR of 2.23; 95% CI 2.13e2.33;
P < 0.0005) (Table 3). Additionally, the HTGW remained
independently associated with subclinical atherosclerosis
after adjustment for the age (y) and the FRS (OR of 1.73;
95% CI 1.66e1.81; P < 0.0005). Similarly, after adjustment
for age (y), FRS, BMI, and alcohol consumption, the HTGW
remained signiﬁcantly associated with subclinical athero-
sclerosis (OR of 1.74; 95% CI 1.61e1.88; P < 0.0005).
Discussion
Our study is the ﬁrst to show a signiﬁcant association
between the HTGW and the FRS in an indigenousTable 3 Hypertriglyceridemic-waist phenotype (HTGW) and Framingham
Cree adults.
Univariate model
Odds ratio (95% CI) Odds ra
All subjects (nZ 332)
HTGW() 1.00 e
HTGW(þ) 2.23 (2.13e2.33)
FRS < 10% 10-year CVD risk e 1.00
FRS  10% 10-year CVD risk 4.49 (2.
a Deﬁned as having sex-speciﬁc common carotid intimal-to-medial arte
b HTGW and FRS, age (y); region (coastal vs. inland) entered as cluster v
c HTGW, FRS, age (y), BMI (kg/m2) and alcohol consumption (yes vs. no)
estimating equation model.population and is consistent with studies reporting on the
association between Framingham risk factors and the
phenotype in healthy women [15], and in non-smoking,
non-diabetic young men [16]. Also, our ﬁndings support
earlier observations indicating the greater importance of
visceral as compared to subcutaneous adipose tissue as
measured by computed tomography for increased meta-
bolic risk [11].
For the ﬁrst time in an indigenous population, both the
HTGW and the FRS were shown to be signiﬁcantly asso-
ciated with sub-clinical atherosclerosis. The C-CAR was
associated with increased risk of CVD events in the U.S.
Atherosclerosis Risk in Communities (ARIC) Study [20].
Our study underscores the importance of both the
HTGW and the Framingham risk prediction algorithm [3]
in identifying at-risk North American Indigenous Peoples.
Global assessment of CVD in relation to subclinical
atherosclerosis is important due to the multiplicative and
interactive effects of CVD risk factors in promotion of
vascular risk [26] and is highly relevant for Indigenous
Peoples who have multiple risk factors [5] which, whenRisk Score (FRS) as associates of subclinical atherosclerosisa among
Multivariate models
Model 1b Model 2c
tio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI)
1.00 1.00
1.73 (1.66e1.81) 1.74 (1.61e1.88)
1.00 1.00
48e8.11) 4.05 (2.09e7.82) 4.08 (2.23e7.46)
rial wall thickness  75th percentile.
ariable in generalized estimating equation model.
; region (coastal vs. inland) entered as cluster variable in generalized
1054 J. Poirier et al.examined singly, may result in individuals being over-
looked for clinical interventions. Although the FRS, as
compared to the HTGW, was a more signiﬁcant predictor
of subclinical atherosclerosis, the phenotype remained
signiﬁcantly predictive of subclinical atherosclerosis even
after adjustment for FRS. This latter ﬁnding is consistent
with the ﬁndings of a healthy population-based study
which showed a greater association of visceral obesity as
compared to FRS risk factors with incident CVD [12]. As the
majority of Cree with the phenotype were categorized at
low FRS risk (69.8%), the use of the FRS alone would miss
detecting those at-risk related to HTGW. This ﬁnding is
compatible with those of the European Prospective
Investigation into Cancer and Nutrition (EPIC)-Norfolk
prospective study in which a greater risk of coronary ar-
tery disease was associated with the HTGW in the lowest
FRS stratum [17].
To our knowledge this is the ﬁrst study to explore the
prevalence of the HTGW in the James Bay Cree (26.7%). The
similar prevalence of HTGW in Cree men (28.2%) and
women (25.2%) agrees with previous ﬁndings in Indige-
nous Peoples using similar NCEP ATP III gender-speciﬁc
WC cut-offs [18,19]. The high rates of HTGW are a cause for
concern. Overall, study participants with HTGW were
relatively young. Our ﬁndings support recent Canadian
guidelines that recommend that individuals of First Na-
tions be screened at an earlier age [27] and that the
metabolic syndrome be used to help identify high-risk
patients in susceptible Canadian populations [28].
Strengths and limitations
Our study has potential limitations, including the inability
to evaluate the temporal relation between C-CAR, FRS and
HTGW. Furthermore, we do not know, with certainty, the
actual atherosclerotic status of participants. Nevertheless,
in several large studies, C-CAR has been considered a
useful tool for detecting generalized atherosclerosis
[20,21]. Due to the observational nature of the study, a
ﬁnal limitation concerns the potential inﬂuence of residual
confounding due to unmeasured confounders on the as-
sociation between C-CAR and HTGW. We, however,
controlled for age as a continuous variable and adjusted
for BMI and alcohol consumption, which in addition to
being potential confounders due to being associated with
CVD, are likely proxies for unmeasured confounders on the
association between the HTGW and C-CAR.
Strengths of the study include ample sample size, in-
clusion of participants free of serious diseases including
CVD based upon medical chart review, adequate partici-
pation rates and standardized quality of collected data.
In summary, our study ﬁndings conﬁrm that among
asymptomatic indigenous James Bay Cree Canadians the
HTGW is associated with the FRS and that both FRS and
HTGW independently associate with subclinical athero-
sclerosis. Pending prospective validation, our results pro-
vide important insights into the relationship between sub-
clinical atherosclerosis and the Framingham risk predic-
tion algorithm [10] and suggest that HTGW phenotypemay be a useful additional screening tool for Indigenous
Peoples.Funding
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